One Health
Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Despite the biological and clinical knowledge of health and disease expanding every single day, people are still dramatically affected by treatable and curable diseases across the world, every single day.
Microorganisms are often associated closely with disease, commonly as a causative agent. However, it is essential to recognise that microbes are also an essential tool in the treatment and prevention of a wide range of diseases. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
One Health Advisory Group members
Sarah Maddocks
An enthusiastic, self-motivated microbiologist and principle investigator with extensive expertise in the field of infectious disease, a good publication record and significant experience in the design, execution and management of research projects.
Jacob Hamilton
Jacob started off as a chemist, completing an undergraduate degree in Pharmaceutical Science at Kingston University in 2017, including a year-long placement at GlaxoSmithKline’s Ware site. During his undergraduate, a module on infectious disease caught his attention and inspired his intertest in microbiology. Jacob then went on to do a Masters by Research in Microbiology in Prof Mark Fielder’s lab, where he investigated the occurrence of antimicrobial resistance markers in the microbiome of birds of prey, during this time he became an active member of AMI, attending various events and writing blog pieces. Currently Jacob is conducting his PhD in Prof Matt Hutching’s lab at the University of East Anglia, where he is researching microbial symbiosis with insect and plant systems, and how these may be a source of novel antimicrobials.
Sally Cutler
Sally's passion for microbiology started with a BSc degree course from University College London from which she graduated in 1981. Sally then worked in diagnostic bacteriology laboratories at The Royal London and Stoke Mandeville Hospitals before moving into a research role on Lyme borreliosis based at Charing Cross Hospital (now part of Imperial College London). Whilst in this post, Sally obtained her PhD in 1992 through part-time study. Sally was awarded the W H Pierce Prize in 1994 and currently holds a Readership in the School of Health and Bioscience at the University of East London. She additionally serves as an associate editor for Clinical Microbiology & Infection and Ticks and Tick-Borne Diseases, as a member of the IBMS Virology Advisory Panel, and on the IBMS London Regional Panel. Her research interests are still largely focussed upon spirochaetes and bacterial zoonoses, particularly those with an impact upon developing countries. Sally has been a member of AMI since the days when it was the Society for Applied Bacteriology. She currently serves on the Meetings Subcommittee and has been a regular participant at AMI meetings for a number of years, both as a presenter and member of the audience.
Joey Shepherd
Joey is a Lecturer in Microbiology at the University of Sheffield’s School of Clinical Dentistry. After graduating from Leeds University in 1995 with a BSc. in Microbiology, and the University of Sheffield with an M.Med.Sci. degree in Microbial Pathogenicity, Joey completed her PhD at the University of Sheffield in 2002. She then moved to Harvard Medical School, Boston, USA, to work for Prof. Peter Libby developing near infra red in vivo molecular probes. Joey returned to the University of Sheffield in 2007 as a PDRA, where she developed a 3D model of infected tissue engineered human skin, subsequently used in several further studies. Joey took up my first academic post as a Senior Lecturer in the Biomedical Research Centre at Sheffield Hallam University in 2014, and was appointed to her current post in April 2015.
Elaine Cloutman-Green
Dr Elaine Cloutman-Green has worked as a Clinical Scientist since 2004. In 2015 she completed a PhD under the NIHR CSO Doctoral Fellowship scheme and her research on prevention of healthcare associated infection led to an NIHR ICA Clinical Lectureship award in 2016. In 2015 she was appointed the first UK based International Ambassador for the Society of Healthcare Epidemiology of America. In 2016 she became a Fellow of the Higher Education Academy, Royal College of Pathologists and was appointed as a NICE Expert. She represents Healthcare Scientists as part of the ACB, and as Country Ambassador for the American Society of Microbiology.
Hannah Trivett
Hannah completed her undergraduate degree in Microbiology at the University of Liverpool in 2020. During her degree, she completed a summer placement funded by The Wellcome Trust to characterise phenotypes of invasive non-typhoidal Salmonella. Hannah is currently undertaking a PhD in Medical Microbiology, exploring the advances in next-generation sequencing to detect gastroenteric pathogens directly from stool. She is interested in applying her research to hospital settings to positively impact diagnostics in public health. Alongside her PhD, Hannah has been an active member of AMI as the Science Communication Officer for the Early Career Scientist (ECS) committee. She has played an integral role in organising ECS virtual and in-person conferences, producing content for The Microbiologist and interviewing key members of the Microbiology community, such as Prof Dame Sally Davies and Prof Sir Jonathan Van Tam.
- Twitter:
- @HannahTriv
Guadalupe Virginia Nevarez Moorillon
Dr. Nevárez-Moorillón has been a full-time professor at the School of Chemical Sciences, Autonomous University of Chihuahua, Mexico, for the last 35 years. She graduated as a bacteriological chemist from the Autonomous University of Chihuahua. She completed her Ph.D. in Biology from the University of North Texas studying the bioremediation of soil contaminated with hydrocarbons, under the supervision of Dr. Gerard Roland Vela. She is a member of the National Outstanding Researchers System of Mexico (Level II) and has been granted the National Award on Food Science and Technology. She is also a regular member of the Mexican Academy of Sciences
Her research interests include environmental microbiology, as well as predictive microbiology applied to food systems, the role of lactic acid bacteria in traditional fermented foods, and antimicrobial properties of spices, such as clove and oregano. Under her supervision, more than 50 undergraduate students, as well as more than 50 master students and 15 doctoral students have completed their degrees.
Blessing Mbaebie Oyedemi
Dr Blessing Mbaebie Oyedemi is a research fellow at Nottingham Trent University with research interest in natural product drug discovery for molecular mechanisms of antimicrobial resistance research (AMR), both in academia and clinical research settings. As an AMI member, her passion resonates as an advocate for sustainable antimicrobial interventions through research, strengthening education and promoting policy.
She believes strongly in the values of AMI and the opportunities provided to all levels of scientists, researchers, and all public walks of life to be a change agent trying to solve everyday challenges and influence change through microbiology
Zina Alfahl
Zina joined the School of Pharmacy at Queen’s University Belfast, UK in September 2018 to purse her PhD degree in the relationship between airway microbiome composition, inflammation and clinical outcomes in patients with Bronchiectasis. In 2018, Zina acquired a BSc (Hons) in Pharmacy from Al Ain University of Science and Technology, UAE. In 2019, she was awarded the Associate Fellowship of the Higher Education Academy (AFHEA) award. Zina is currently the Postgraduate Chair and acting as a student representative member at the SWAN SAT team for gender equality at the School of Pharmacy, QUB. Zina is interested in engaging with scientific community and in promoting microbiology.
- Twitter:
- @AlfahlZina
Supram Hosuru Subramanya
Dr. Supram HS is a medical microbiologist, with a Doctorate in Medical Microbiology from Manipal Academy of Higher Education, India. Currently, he is working as Assistant Professor in MCOMS, Nepal. He is experienced in diagnostic microbiology and teaching undergraduate and postgraduate medical students. He is a member of the Infection Control Committee and Hospital Waste Management Committee at Manipal Teaching Hospital, Nepal. His area of research is infectious diseases, antimicrobial resistance (One-Health perspective), and emerging fungal infections. Since 2014, he has been working in various international collaborative research projects. His research yielded more than 45 publications in international medical journals.
He is also an active reviewer for several academic journals such as PlosOne, Lancet-ID, Frontiers, Journal of Chemotherapy, JAC-AMR, BMC series, EC Microbiology, AJMS, etc. He is serving as Academic Editor of PLoS ONE, Research Editor of JAC-AMR official journal of the British Society for Antimicrobial Chemotherapy and Section Editor in Nepal Journal of Epidemiology. Based on demonstrated excellence in research and commitment to advance society, Dr. Supram is appointed as International Young Ambassador for Science to Nepal from the American Society for Microbiology in 2020. He also received more than 20 awards for his research from various international scientific societies.
Hasan Yesilkaya
I studied veterinary medicine at Ankara University Turkey. After completion of my PhD in Leicester on oxidative stress resistance of important human pathogen Streptococcus pneumoniae under the supervision of Prof Peter Andrew I worked in Utrecht as an EMBO fellow then moved to Aberdeen University where I studied transposable elements of Mycobacterium tuberculosis as a postdoctoral fellow. Since 2003 I have been working as a research fellow (2003-2012) lecturer (2012-2020) then as an associate professor (2020 onward) at the University of Leicester.
Binod Rayamajhee
Binod joined the School of Optometry and Vision Science, UNSW, Sydney in March 2020 to pursue his PhD project on corneal infection focusing Acanthamoeba keratitis under the supervision of Dr Nicole Carnt and Prof Mark Willcox of UNSW, Sydney and Prof Fiona L. Henriquez from the Infection and Microbiology Research Group at the University of the West of Scotland (UWS). Binod holds a Master’s in medical microbiology from Tribhuvan University, Nepal in 2017. After completion of his master, Binod worked in different organisations in his home country focusing on infectious diseases, antimicrobial resistance and infection control where he has cofounded a research institute in 2017 targeting infectious diseases and has received some noteworthy grants in the past. Binod has profound interest in interdisciplinary collaboration with diverse groups of people for open science, science advocacy, and science for all so, advocating, and championing for translational research are particular interests of Binod outside of his laboratory walls. On the same note, he has served as a community Ambassador of eLife Sciences Publications Ltd., UK (2019 - 2020) and an international representative for the Early Career Scientists (ECS) Committee, AMI (2018 - 2019).
- Twitter:
- @RayamajheeBinod
Delveen Ibrahim
Since 2006, I have been a lecturer at the University of Duhok in the Biology Department of the College of Science. My PhD in Microbiology from Nottingham University in the UK was awarded to me in 2017. My doctoral research focused on ESBL-producing E. coli and multi-drug resistance. This study involved phenotypic evaluation of the selected isolates, molecular characterization of several resistance genes, whole genome sequencing of selected strains to examine the genetic and genomic context surrounding -lactamase genes. My goal is to better understand how bacteria are killed by current and previous antimicrobial treatments, as well as how bacteria develop resistance to them. Currently, I am a Global ambassador for AMI and a junior editor for Letters in Applied Microbiology (LAM) journal.
